サンプル依頼リスト カート
  • English
  • Korean
表紙：ケトライドの世界市場レポート 2024年
市場調査レポート
商品コード
1415665

ケトライドの世界市場レポート 2024年

Ketolides Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ケトライドの世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

ケトライド市場規模は近年力強く成長しています。2023年の30億7,000万米ドルから2024年には32億2,000万米ドルに、CAGR5.0％で拡大します。歴史的な期間の成長は、感染症の有病率の増加、抗生物質の消費量の増加、感染症に対する効果的で便利な治療法の需要、政府の取り組みに起因しています。

ケトライドの市場規模は、今後数年間で安定した成長が見込まれます。2028年にはCAGR4.4％で38億2,000万米ドルに成長します。予測期間の成長は、ケトライドの研究開発活動への投資、感染症スクリーニングプログラムの増加、ヘルスケア支出の増加、抗菌薬スチュワードシップに対する意識の高まりに起因しています。予測期間における主な動向としては、感染症に対する革新的な治療法、標的療法の開発、感染症の診断と治療の進歩、新しいケトライド製剤の開発などが挙げられます。

感染症の流行の高まりは、当面のケトライド市場の拡大を牽引すると予想されます。感染症は、細菌、ウイルス、真菌、寄生虫など様々な病原体によって引き起こされる幅広い疾患を包含しており、これらの病原体は人から人へと感染し、様々な症状や健康合併症を引き起こします。これらの病気の中でも、結核は重要な懸念事項として際立っています。ケトライドは、感染症の治療に利用される抗生物質の一種であるが、結核対策の重要な要素である細胞内活動に有効であることから、結核管理の可能性が注目されています。例えば、2022年10月現在、世界保健機関（WHO）が発表した「世界結核レポート」によると、結核患者数は世界全体で4.5％増加し、2020年の1,010万人から2021年には1,060万人になると予測されています。このように、感染症の急増がケトライド市場成長の原動力となっています。

ケトライド市場の成長は、主に慢性副鼻腔炎の有病率の増加に起因しています。慢性副鼻腔炎は、鼻腔周辺の副鼻腔における持続的な炎症が特徴です。ケトライドは、免疫調節作用と抗炎症作用を持つ抗生物質の一種で、様々な病状の治療に応用されています。慢性副鼻腔炎は副鼻腔の炎症を伴うことから、ケトライドはこの炎症を緩和し、関連する症状を緩和する役割を果たします。例えば、米国疾病予防管理センター（CDC）が2022年1月に発表したデータによると、米国では成人の約11.6％が副鼻腔炎の診断を受けています。その結果、慢性副鼻腔炎の拡大がケトライド市場の成長の原動力となっています。

2023年のケトライド市場で最大の地域は北米でした。ケトライドレポートの対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東およびアフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界のケトライド市場、医薬品タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • テリスロマイシン
  • セスロマイシン
  • ソリスロマイシン
  • 世界のケトライド市場、適応症別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 気管支炎
  • 肺炎
  • 副鼻腔炎
  • 扁桃炎または咽頭炎
  • 世界のケトライド市場、微生物別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 肺炎連鎖球菌
  • ヘモフィルス・インフルエンザ
  • モラクセラ・カタルハリス
  • クラミドフィラ・ニューモニエ
  • マイコプラズマ肺炎
  • 世界のケトライド市場、流通チャネル別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • その他

第7章 地域および国の分析

  • 世界のケトライド市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
  • 世界のケトライド市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • ケトライド市場の競合情勢
  • ケトライド市場の企業プロファイル
    • Pfizer Inc.
    • F. Hoffmann-La Roche Ltd.
    • Merck &Co. Inc.
    • Bayer AG
    • Novartis AG

第31章 その他の主要および革新的な企業

  • Sanofi S.A.
  • Bristol-Myers Squibb Company
  • AstraZeneca PLC
  • Abbott Laboratories
  • GSK PLC
  • Takeda Pharmaceutical Company Limited
  • Eli Lilly and Company
  • Teva Pharmaceutical Industries Ltd.
  • Astellas Pharma Inc.
  • Daiichi Sankyo Company Limited
  • Shionogi & Company Limited
  • Dr. Reddys Laboratories Ltd.
  • Taisho Pharmaceutical Co. Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • Zhejiang Yongtai Technology Co. Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r12264

“Ketolides Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ketolides market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ketolides? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The ketolides market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Drug Type: Telithromycin; Cethromycin; Solithromycin
  • 2) By Indication: Bronchitis; Pneumonia; Sinusitis; Tonsillitis Or Pharyngitis
  • 3) By Microorganism: Streptococcus Pneumoniae; Haemophilus Influenzae; Moraxella Catarrhalis; Chlamydophila Pneumoniae; Mycoplasma Pneumoniae
  • 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
  • Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Bayer AG; Novartis AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Ketolides, a class of antibiotics within the macrolide group, are derived from erythromycin, a 14-membered macrolide. They are created by replacing the cladinose sugar with a keto-group and incorporating a cyclic carbamate group into the lactone ring structure. Ketolides exert their antibiotic effects by inhibiting protein synthesis, thus impeding the production of essential proteins vital for bacterial maintenance and survival.

The primary drugs falling under the ketolides category include telithromycin, cethromycin, and solithromycin. Telithromycin, a semi-synthetic antibiotic of the ketolide class, is deployed in the treatment of respiratory tract infections. These antibiotics find application in a range of conditions, including bronchitis, pneumonia, sinusitis, tonsillitis, and pharyngitis. They target various microorganisms such as Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Chlamydophila pneumoniae, and Mycoplasma pneumoniae. Ketolides are distributed through diverse channels, including hospital pharmacies, retail pharmacies, online pharmacies, and others.

The ketolides market research report is one of a series of new reports from The Business Research Company that provides ketolides market statistics, including ketolides industry global market size, regional shares, competitors with a ketolides market share, detailed ketolides market segments, market trends and opportunities and any further data you may need to thrive in the ketolides industry. This ketolides market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ketolides market size has grown strongly in recent years. It will grow from $3.07 billion in 2023 to $3.22 billion in 2024 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to increasing prevalence of infectious diseases, growing consumption of antibiotics, demand for effective and convenient treatments for infectious diseases, government initiatives.

The ketolides market size is expected to see steady growth in the next few years. It will grow to $3.82 billion in 2028 at a compound annual growth rate (CAGR) of 4.4%. The growth in the forecast period can be attributed to investments in research and development activities for ketolides, growing number of screening programs for infectious diseases, incremental healthcare spending. growing awareness of antimicrobial stewardship. Major trends in the forecast period include innovative treatments for infectious diseases, development of targeted therapies, advancements in diagnosis and treatment of infectious diseases, development of new ketolide formulations.

The escalating prevalence of infectious diseases is anticipated to drive the expansion of the ketolides market in the foreseeable future. Infectious diseases encompass a broad spectrum of illnesses caused by various pathogens, including bacteria, viruses, fungi, or parasites, which can be transmitted from one person to another, resulting in a wide array of symptoms and health complications. Among these diseases, tuberculosis stands out as a significant concern. Ketolides, a class of antibiotics utilized in the treatment of infectious diseases, have garnered attention for their potential in managing tuberculosis due to their effectiveness in intracellular activities, a key factor in combating tuberculosis. For instance, as of October 2022, the World Health Organization's Global Tuberculosis Report revealed a projected 4.5% increase in tuberculosis (TB) cases globally, with an estimated 10.6 million cases in 2021, up from 10.1 million cases in 2020. As such, the surging prevalence of infectious diseases is the driving force behind the growth of the ketolides market.

The ketolides market is witnessing growth, primarily attributed to the increasing prevalence of chronic sinusitis. Chronic sinusitis is characterized by persistent inflammation in the sinus cavities around the nasal passages. Ketolides, a class of antibiotics with immunomodulatory and anti-inflammatory properties, find application in the treatment of various medical conditions. Given that chronic sinusitis involves inflammation of the sinuses, ketolides play a role in mitigating this inflammation and alleviating associated symptoms. For example, data from the US-based Centers for Disease Control and Prevention (CDC) as of January 2022 indicated that approximately 11.6% of adults in the United States had received diagnoses of sinusitis. Consequently, the expanding occurrence of chronic sinusitis serves as a driving force behind the growth of the ketolides market.

Major players in the ketolides market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GSK PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Shionogi & Company Limited, Dr. Reddys Laboratories Ltd., Taisho Pharmaceutical Co. Ltd., Glenmark Pharmaceuticals Ltd., Zhejiang Yongtai Technology Co. Ltd., Corden Pharma GmbH, Optimer Pharmaceuticals Inc., Vivimed Labs Limited, Wockhardt Ltd., Advanced Life Sciences Holdings Inc .

The growth of the ketolides market faces hindrances due to the side effects associated with the medication. These side effects, which include diarrhea, nausea, vomiting, and dizziness, present significant challenges and are expected to limit market expansion over the projected period. Ketolides, as a class of antibiotics used to combat bacterial infections, exhibit efficacy in eradicating or inhibiting the growth of bacteria. However, they also carry a range of adverse effects on the body. For instance, as of October 2021, according to information provided by RxList, a US-based online medical resource company, diarrhea is a commonly observed side effect of ketolides, such as telithromycin. Clinical trials involving patients with respiratory tract infections reported that telithromycin was associated with diarrhea in approximately 10.8% of cases. Consequently, the hindrance posed by medication side effects is impeding the growth of the ketolides market.

The leading companies within the ketolides market are strongly committed to pioneering innovative drugs and treatment approaches, with the aim of gaining a competitive edge and maintaining their market position. For instance, AliquantumRx Inc., a US-based biotechnical research company, which, in June 2023, celebrated the approval of a patent by the United States Patent and Trademark Office (USPTO), a key agency under the Department of Commerce. This patent, titled 'salts and polymorphs of cethromycin for the treatment of bacterial and protozoan disease,' pertains to cethromycin, a ketolide antibiotic that demonstrates effectiveness against various infectious diseases caused by both bacteria and protozoa. These conditions encompass malaria, babesiosis, toxoplasmosis, diarrhea, and more. Notably, this newly granted patent significantly expands the possibilities for the use of cethromycin, potentially lowering the barriers to its commercialization and facilitating its application in treating a broader range of diseases.

Growth Of The Ketolides Market Is Being Driven By The Expanding Healthcare Industry

North America was the largest region in the ketolides market in 2023. The regions covered in ketolides report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the ketolides market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ketolides market consists of sales of solithera and ketek, arylalkyl and macrolactone rings. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Ketolides Market Characteristics

3. Ketolides Market Trends And Strategies

4. Ketolides Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Ketolides Market Size and Growth

  • 5.1. Global Ketolides Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Ketolides Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Ketolides Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Ketolides Market Segmentation

  • 6.1. Global Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Telithromycin
  • Cethromycin
  • Solithromycin
  • 6.2. Global Ketolides Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Bronchitis
  • Pneumonia
  • Sinusitis
  • Tonsillitis Or Pharyngitis
  • 6.3. Global Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Streptococcus Pneumoniae
  • Haemophilus Influenzae
  • Moraxella Catarrhalis
  • Chlamydophila Pneumoniae
  • Mycoplasma Pneumoniae
  • 6.4. Global Ketolides Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Other Distribution Channels

7. Ketolides Market Regional And Country Analysis

  • 7.1. Global Ketolides Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Ketolides Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Ketolides Market

  • 8.1. Asia-Pacific Ketolides Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Ketolides Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Ketolides Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Ketolides Market

  • 9.1. China Ketolides Market Overview
  • 9.2. China Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Ketolides Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Ketolides Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Ketolides Market

  • 10.1. India Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Ketolides Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Ketolides Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Ketolides Market

  • 11.1. Japan Ketolides Market Overview
  • 11.2. Japan Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Ketolides Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Ketolides Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Ketolides Market

  • 12.1. Australia Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Ketolides Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Ketolides Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Ketolides Market

  • 13.1. Indonesia Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Ketolides Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Ketolides Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Ketolides Market

  • 14.1. South Korea Ketolides Market Overview
  • 14.2. South Korea Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Ketolides Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Ketolides Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Ketolides Market

  • 15.1. Western Europe Ketolides Market Overview
  • 15.2. Western Europe Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Ketolides Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Ketolides Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Ketolides Market

  • 16.1. UK Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Ketolides Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Ketolides Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Ketolides Market

  • 17.1. Germany Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Ketolides Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Ketolides Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Ketolides Market

  • 18.1. France Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Ketolides Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Ketolides Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Ketolides Market

  • 19.1. Italy Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Ketolides Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Ketolides Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Ketolides Market

  • 20.1. Spain Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Ketolides Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Ketolides Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Ketolides Market

  • 21.1. Eastern Europe Ketolides Market Overview
  • 21.2. Eastern Europe Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Ketolides Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Ketolides Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Ketolides Market

  • 22.1. Russia Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Ketolides Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Ketolides Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Ketolides Market

  • 23.1. North America Ketolides Market Overview
  • 23.2. North America Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Ketolides Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Ketolides Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Ketolides Market

  • 24.1. USA Ketolides Market Overview
  • 24.2. USA Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Ketolides Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Ketolides Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Ketolides Market

  • 25.1. Canada Ketolides Market Overview
  • 25.2. Canada Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Ketolides Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Ketolides Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Ketolides Market

  • 26.1. South America Ketolides Market Overview
  • 26.2. South America Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Ketolides Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Ketolides Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Ketolides Market

  • 27.1. Brazil Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Ketolides Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Ketolides Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Ketolides Market

  • 28.1. Middle East Ketolides Market Overview
  • 28.2. Middle East Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Ketolides Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Ketolides Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Ketolides Market

  • 29.1. Africa Ketolides Market Overview
  • 29.2. Africa Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Ketolides Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Ketolides Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Ketolides Market Competitive Landscape And Company Profiles

  • 30.1. Ketolides Market Competitive Landscape
  • 30.2. Ketolides Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. F. Hoffmann-La Roche Ltd.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Merck & Co. Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Bayer AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Novartis AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Ketolides Market Other Major And Innovative Companies

  • 31.1. Sanofi S.A.
  • 31.2. Bristol-Myers Squibb Company
  • 31.3. AstraZeneca PLC
  • 31.4. Abbott Laboratories
  • 31.5. GSK PLC
  • 31.6. Takeda Pharmaceutical Company Limited
  • 31.7. Eli Lilly and Company
  • 31.8. Teva Pharmaceutical Industries Ltd.
  • 31.9. Astellas Pharma Inc.
  • 31.10. Daiichi Sankyo Company Limited
  • 31.11. Shionogi & Company Limited
  • 31.12. Dr. Reddys Laboratories Ltd.
  • 31.13. Taisho Pharmaceutical Co. Ltd.
  • 31.14. Glenmark Pharmaceuticals Ltd.
  • 31.15. Zhejiang Yongtai Technology Co. Ltd.

32. Global Ketolides Market Competitive Benchmarking

33. Global Ketolides Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Ketolides Market

35. Ketolides Market Future Outlook and Potential Analysis

  • 35.1 Ketolides Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Ketolides Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Ketolides Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer